Literature DB >> 15912621

Rabeprazole controls GERD symptoms in a patient for whom treatment with lansoprazole failed: first report of "cluster GERD.".

David S Oh1, Gordon V Ohning, Joseph R Pisegna.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15912621      PMCID： PMC6719682          DOI： 10.1007/s10620-005-2652-3

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  13 in total

1.  An evidence-based appraisal of reflux disease management--the Genval Workshop Report.

Authors: 
Journal:  Gut       Date:  1999-04       Impact factor: 23.059

2.  Sites of reaction of the gastric H,K-ATPase with extracytoplasmic thiol reagents.

Authors:  M Besancon; A Simon; G Sachs; J M Shin
Journal:  J Biol Chem       Date:  1997-09-05       Impact factor: 5.157

3.  Efficacy of famotidine 20 mg twice a day versus 40 mg twice a day in the treatment of erosive or ulcerative reflux esophagitis.

Authors:  I C Wesdorp; W Dekker; H P Festen
Journal:  Dig Dis Sci       Date:  1993-12       Impact factor: 3.199

Review 4.  Review article: the pharmacology of rabeprazole.

Authors:  M P Williams; R E Pounder
Journal:  Aliment Pharmacol Ther       Date:  1999-08       Impact factor: 8.171

5.  Gastroesophageal reflux disease: prevalence, clinical, endoscopic and histopathological findings in 1,128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms.

Authors:  M Voutilainen; P Sipponen; J P Mecklin; M Juhola; M Färkkilä
Journal:  Digestion       Date:  2000       Impact factor: 3.216

6.  Rabeprazole produces rapid, potent, and long-acting inhibition of gastric acid secretion in subjects with Helicobacter pylori infection.

Authors:  G V Ohning; R C Barbuti; T O Kovacs; B Sytnik; T J Humphries; J H Walsh
Journal:  Aliment Pharmacol Ther       Date:  2000-06       Impact factor: 8.171

7.  Effects of oral rabeprazole on oesophageal and gastric pH in patients with gastro-oesophageal reflux disease.

Authors:  M Robinson; P N Maton; S Rodriguez; B Greenwood; T J Humphries
Journal:  Aliment Pharmacol Ther       Date:  1997-10       Impact factor: 8.171

8.  Three year follow up of patients with gastrooesophageal reflux disease.

Authors:  N E Schindlbeck; A G Klauser; G Berghammer; W Londong; S A Müller-Lissner
Journal:  Gut       Date:  1992-08       Impact factor: 23.059

9.  Famotidine relieves symptoms of gastroesophageal reflux disease and heals erosions and ulcerations. Results of a multicenter, placebo-controlled, dose-ranging study. USA Merck Gastroesophageal Reflux Disease Study Group.

Authors:  S M Sabesin; R G Berlin; T J Humphries; D C Bradstreet; K L Walton-Bowen; S Zaidi
Journal:  Arch Intern Med       Date:  1991-12

10.  Rabeprazole is superior to omeprazole for the inhibition of peptone meal-stimulated gastric acid secretion in Helicobacter pylori-negative subjects.

Authors:  G V Ohning; J H Walsh; J R Pisegna; A Murthy; J Barth; T O G Kovacs
Journal:  Aliment Pharmacol Ther       Date:  2003-05-01       Impact factor: 8.171
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.